Memory Pharmaceuticals Corp.
Memory Pharmaceuticals, a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating central nervous system (CNS) disorders, many of which exhibit significant impairment of memory and other cognitive function. These conditions include neurological diseases associated with aging, such as Alzheimer’s disease, and also include certain psychiatric disorders such as schizophrenia, bipolar disorder and depression. We leverage our extensive knowledge of the neuronal pathways involved in memory formation and cognition to identify highly relevant targets. The entrepreneurial, interdisciplinary environment at Memory Pharmaceuticals enables our experts in molecular biology, CNS medicinal chemistry, and preclinical drug development to work together from the outset of the discovery process and throughout the screening, identification, and optimization of potential drug candidates. Advanced capabilities and in-house expertise in drug discovery and development have allowed us to generate a diverse pipeline of promising drug development programs.